From 1 July 2024, we are introducing temporary new arrangements for GMP inspections of domestic and overseas manufacturers of medicines, Active Pharmaceutical Ingredients (APIs), biologicals and blood products. These inspections will be called ‘surveillance inspections.’..[TGA]